Vineet Laboratories: SEBI Takeover Disclosure filed under Regulation 31(4)

Regulatory 22 Jun 2026 · Filed / open· ✓ Verified

A Srinivasa Raju has submitted a disclosure under Regulation 31(4) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011 to the NSE. This regulation requires disclosure of acquisitions of shares that trigger a mandatory open offer obligation. The specific acquisition size, consideration, and conditions are not detailed in the publicly available excerpt; the full disclosure document should be accessed directly from NSE archives to establish deal parameters.

Why it mattersRegulation 31(4) disclosures flag either a completed substantial acquisition (>25% of voting capital) or open offer trigger; counsel should obtain the full disclosure document from NSE to determine whether an open offer is mandated and the timing/structure of any required shareholder communication.
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]

Sources

Open in the live tracker →

Related deals